Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott J Robbie

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Human Gene Therapy|June 16, 2011
Long-term preservation of cones and improvement in visual function following gene therapy in a mouse model of leber congenital amaurosis caused by guanylate cyclase-1 deficiencyMarija Mihelec, Rachael A Pearson, Scott J Robbie, et al.
Experimental Eye Research|December 13, 2012
Ccl2, Cx3cr1 and Ccl2/Cx3cr1 chemokine deficiencies are not sufficient to cause age-related retinal degenerationUlrich F O Luhmann, Livia S Carvalho, Scott J Robbie, et al.
Scientific Reports|October 31, 2013
CD200R signaling inhibits pro-angiogenic gene expression by macrophages and suppresses choroidal neovascularizationShintaro Horie, Scott J Robbie, Jian Liu, et al.
The American Journal of Pathology|July 19, 2015
Novel CCR3 Antagonists Are Effective Mono- and Combination Inhibitors of Choroidal Neovascular Growth and Vascular PermeabilityNori Nagai, Meihua Ju, Kanako Izumi-Nagai, et al.
The Journal of Gene Medicine|April 3, 2009
Subretinal delivery of adeno-associated virus serotype 2 results in minimal immune responses that allow repeat vector administration in immunocompetent miceSusie E Barker, Cathryn A Broderick, Scott J Robbie, et al.
Investigative Ophthalmology & Visual Science|February 7, 2013
Assessing a novel depot delivery strategy for noninvasive administration of VEGF/PDGF RTK inhibitors for ocular neovascular diseaseScott J Robbie, Peter Lundh von Leithner, Meihua Ju, et al.
Journal of Vision|November 26, 2015
Spectral sensitivity measurements reveal partial success in restoring missing rod function with gene therapyCaterina Ripamonti, G Bruce Henning, Scott J Robbie, et al.
The American Journal of Pathology|June 17, 2015
IL-4 regulates specific Arg-1(+) macrophage sFlt-1-mediated inhibition of angiogenesisWei-Kang Wu, Anastasios Georgiadis, David A Copland, et al.
Investigative Ophthalmology & Visual Science|September 27, 2014
Nature of the visual loss in observers with Leber's congenital amaurosis caused by specific mutations in RPE65Caterina Ripamonti, G Bruce Henning, Robin R Ali, et al.
The New England Journal of Medicine|May 5, 2015
Long-term effect of gene therapy on Leber's congenital amaurosisJames W B Bainbridge, Manjit S Mehat, Venki Sundaram, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Human Gene Therapy|June 16, 2011
Long-term preservation of cones and improvement in visual function following gene therapy in a mouse model of leber congenital amaurosis caused by guanylate cyclase-1 deficiencyMarija Mihelec, Rachael A Pearson, Scott J Robbie, et al.
Experimental Eye Research|December 13, 2012
Ccl2, Cx3cr1 and Ccl2/Cx3cr1 chemokine deficiencies are not sufficient to cause age-related retinal degenerationUlrich F O Luhmann, Livia S Carvalho, Scott J Robbie, et al.
Scientific Reports|October 31, 2013
CD200R signaling inhibits pro-angiogenic gene expression by macrophages and suppresses choroidal neovascularizationShintaro Horie, Scott J Robbie, Jian Liu, et al.
The American Journal of Pathology|July 19, 2015
Novel CCR3 Antagonists Are Effective Mono- and Combination Inhibitors of Choroidal Neovascular Growth and Vascular PermeabilityNori Nagai, Meihua Ju, Kanako Izumi-Nagai, et al.
The Journal of Gene Medicine|April 3, 2009
Subretinal delivery of adeno-associated virus serotype 2 results in minimal immune responses that allow repeat vector administration in immunocompetent miceSusie E Barker, Cathryn A Broderick, Scott J Robbie, et al.
Investigative Ophthalmology & Visual Science|February 7, 2013
Assessing a novel depot delivery strategy for noninvasive administration of VEGF/PDGF RTK inhibitors for ocular neovascular diseaseScott J Robbie, Peter Lundh von Leithner, Meihua Ju, et al.
Journal of Vision|November 26, 2015
Spectral sensitivity measurements reveal partial success in restoring missing rod function with gene therapyCaterina Ripamonti, G Bruce Henning, Scott J Robbie, et al.
The American Journal of Pathology|June 17, 2015
IL-4 regulates specific Arg-1(+) macrophage sFlt-1-mediated inhibition of angiogenesisWei-Kang Wu, Anastasios Georgiadis, David A Copland, et al.
Investigative Ophthalmology & Visual Science|September 27, 2014
Nature of the visual loss in observers with Leber's congenital amaurosis caused by specific mutations in RPE65Caterina Ripamonti, G Bruce Henning, Robin R Ali, et al.
The New England Journal of Medicine|May 5, 2015
Long-term effect of gene therapy on Leber's congenital amaurosisJames W B Bainbridge, Manjit S Mehat, Venki Sundaram, et al.
Pageof 2